ATE112278T1 - 1,2,3,3a,8,8a-hexahydro-1,3a,8- trimethylpyrrolo(2,3-b>indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. - Google Patents
1,2,3,3a,8,8a-hexahydro-1,3a,8- trimethylpyrrolo(2,3-b>indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.Info
- Publication number
- ATE112278T1 ATE112278T1 AT87110184T AT87110184T ATE112278T1 AT E112278 T1 ATE112278 T1 AT E112278T1 AT 87110184 T AT87110184 T AT 87110184T AT 87110184 T AT87110184 T AT 87110184T AT E112278 T1 ATE112278 T1 AT E112278T1
- Authority
- AT
- Austria
- Prior art keywords
- loweralkyl
- methyl
- hydrogen
- arylloweralkyl
- trimethylpyrrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88599186A | 1986-07-16 | 1986-07-16 | |
US07/049,894 US4791107A (en) | 1986-07-16 | 1987-05-15 | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE112278T1 true ATE112278T1 (de) | 1994-10-15 |
Family
ID=26727666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT87110184T ATE112278T1 (de) | 1986-07-16 | 1987-07-15 | 1,2,3,3a,8,8a-hexahydro-1,3a,8- trimethylpyrrolo(2,3-b>indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. |
Country Status (15)
Country | Link |
---|---|
US (9) | US4791107A (de) |
EP (1) | EP0253372B1 (de) |
JP (1) | JP2716099B2 (de) |
KR (1) | KR960003614B1 (de) |
AT (1) | ATE112278T1 (de) |
AU (1) | AU612583B2 (de) |
CA (1) | CA1307788C (de) |
DE (1) | DE3750596T2 (de) |
DK (1) | DK367987A (de) |
ES (1) | ES2060585T3 (de) |
HU (1) | HU206717B (de) |
IE (1) | IE64429B1 (de) |
IL (1) | IL83190A0 (de) |
NZ (1) | NZ221060A (de) |
PT (1) | PT85334B (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5306825A (en) * | 1984-03-01 | 1994-04-26 | Consiglio Nazionale Delle Ricerche | Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process |
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
IT1225462B (it) * | 1987-04-03 | 1990-11-14 | Mediolanum Farmaceutici Srl | Sali organici di derivati della fisostigmina |
US5280032A (en) * | 1989-02-14 | 1994-01-18 | Toyama Chemical Co., Ltd. | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
US4971992A (en) * | 1989-03-27 | 1990-11-20 | Hoechst-Roussel Pharmaceuticals Inc. | Carbonate derivatives of eseroline |
US5387590A (en) * | 1989-08-30 | 1995-02-07 | Pfizer Inc. | Benzazabicyclic carbamates as novel cholinesterase inhibitors |
US4937341A (en) * | 1989-09-28 | 1990-06-26 | Hoechst-Roussel Pharmaceuticals Inc. | Process for preparing N-aminocarbarbamates related to physostigmine |
US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
US5260452A (en) * | 1989-11-03 | 1993-11-09 | Hoechst-Roussel Pharmaceuticals Inc. | 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof |
US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US5177101A (en) * | 1989-11-30 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
DK0438796T3 (da) | 1990-01-22 | 1999-05-25 | Hoechst Marion Roussel Inc | Fremgangsmåde til enantioselektiv syntese af alkylerede oxindoler, som anvendes som mellemprodukter ved fremstilling af phy |
US5840915A (en) * | 1990-01-22 | 1998-11-24 | Hoechst Marion Roussel, Inc. | Process for the enatioselective synthesis of intermediates used |
US4983616A (en) * | 1990-02-01 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds |
US5428043A (en) * | 1990-02-08 | 1995-06-27 | Pfizer Inc. | Tricyclic-cyclic amines as novel cholinesterase inhibitors |
TW197442B (de) * | 1990-02-08 | 1993-01-01 | Pfizer | |
AU634654B2 (en) * | 1990-05-11 | 1993-02-25 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments |
US5216017A (en) * | 1990-05-11 | 1993-06-01 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrrolo[2,3-b]indole-ketones and analogs |
AU634380B2 (en) * | 1990-05-17 | 1993-02-18 | Hoechst-Roussel Pharmaceuticals Incorporated | Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments |
ES2113859T3 (es) | 1990-06-27 | 1998-05-16 | Hoechst Marion Roussel Inc | Tetrahidroisoquinolinilcarbamatos de 1,2,3,3a,8,8a-hexahidro-1,3a,8-trimetilpirrolo(2,3-b)indol. |
ES2103816T3 (es) * | 1990-07-12 | 1997-10-01 | Pfizer | Carbamatos de indano pirrolidina. |
US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
IT1243917B (it) * | 1990-11-20 | 1994-06-28 | Mediolanum Farmaceutici Spa | Derivati della fisostigmina |
EP0606366B1 (de) * | 1991-09-26 | 2003-06-04 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES | Substituierte phenserine und phenylcarbamate von (-)-eserolin, (-)-n1-noreserolin und (-)-n1-benzylnoresorolin als spezifische acetylcholinesterase-inhibitoren |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
US5206260A (en) * | 1991-11-07 | 1993-04-27 | Merck & Co., Inc. | Hexahydropyrrolo[2,3-b]indole derivatives |
IT1253007B (it) * | 1991-12-31 | 1995-07-10 | Aesculapius Farma Srl | Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
JP2873898B2 (ja) * | 1992-04-13 | 1999-03-24 | 富山化学工業株式会社 | ベンゾ[b]チオフェン−5−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法 |
IT1260506B (it) * | 1992-06-01 | 1996-04-09 | Stefano Maiorana | Processo per la preparazione di eseretolo |
IT1254996B (it) * | 1992-06-25 | 1995-10-11 | Mediolanum Farmaceutici Srl | Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione |
FI933264A (fi) * | 1992-07-21 | 1994-01-22 | Hoechst Roussel Pharma | Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin |
DE4226263A1 (de) * | 1992-08-08 | 1994-02-10 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dialkyl-5-hydroxyoxindolen und deren Etherderivaten |
US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
US5571929A (en) * | 1994-12-07 | 1996-11-05 | The United States Of America As Represented By The Department Of Health And Human Services | Resolution and reduction of physostigmine intermediates and derivatives |
US5665880A (en) * | 1996-10-31 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseretholes |
US5677457A (en) * | 1996-12-19 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
CZ297533B6 (cs) * | 1997-07-09 | 2007-01-03 | Axonyx | Použití inhibitorů butyrylcholinesterázy pro léčbu a diagnostiku Alzheimerovy choroby a demence |
WO1999019329A1 (en) * | 1997-10-10 | 1999-04-22 | Chiesi Farmaceutici S.P.A. | A process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activity |
US6499878B1 (en) | 1999-12-21 | 2002-12-31 | Pactiv Corporation | Reclosable packages with barrier properties |
ATE406371T1 (de) * | 2000-11-02 | 2008-09-15 | Us Gov Health & Human Serv | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung |
US6495700B1 (en) | 2002-01-09 | 2002-12-17 | Axonyx, Inc. | Process for producing phenserine and its analog |
US7415565B2 (en) * | 2002-10-31 | 2008-08-19 | Ring Technology Enterprises, Llc | Methods and systems for a storage system with a program-controlled switch for routing data |
US7897639B2 (en) | 2003-10-21 | 2011-03-01 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
US20050272804A1 (en) * | 2004-06-08 | 2005-12-08 | Axonyx, Inc | Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor |
US20080045500A1 (en) * | 2004-07-01 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Nerve Regeneration Stimulator |
EP1856036B1 (de) * | 2004-11-08 | 2016-12-14 | Emcure Pharmaceuticals Limited | Effizientes verfahren zur herstellung von (s)-3-[(1-dimethylamino)ethyl]-phenyl-n-ethyl-n-methylcarbamat |
EP2125709A2 (de) * | 2007-02-02 | 2009-12-02 | Colucid Pharmaceuticals, Inc. | Verbindungen zur hemmung von cholinesterase |
US7964613B2 (en) | 2007-02-28 | 2011-06-21 | Asahi Kasei Pharma Corporation | Sulfonamide compound |
JP2010533717A (ja) * | 2007-07-18 | 2010-10-28 | コルシド・ファーマシューティカルズ・インコーポレイテッド | 覚醒を促進する方法 |
US8593728B2 (en) * | 2009-02-19 | 2013-11-26 | Toyota Motor Engineering & Manufacturing North America, Inc. | Multilayer photonic structures |
WO2010067594A1 (ja) * | 2008-12-11 | 2010-06-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘキサヒドロピロロインドール誘導体 |
US10004962B2 (en) * | 2016-07-18 | 2018-06-26 | Bk Brown Enterprises, Inc. | Sport stick training weight |
KR101963634B1 (ko) * | 2017-03-29 | 2019-03-29 | 주식회사 아리바이오 | 금강송 추출물을 이용한 음료의 제조방법 |
EP3628315A1 (de) | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Kombination aus acetylcholinesterase-inhibitor und 5-ht4-rezeptoragonist als neuroprotektives mittel zur behandlung von neurodegenerativen krankheiten |
US20230113944A1 (en) * | 2020-01-10 | 2023-04-13 | The Regents Of The University Of California | Compositions and methods for the treatment of neurodegenerative diseases |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2678899A (en) * | 1952-04-11 | 1954-05-18 | Kremcrs Urban Co | Stable solution of physostigmine |
US2909530A (en) * | 1958-09-26 | 1959-10-20 | Grace W R & Co | Physostigmine derivatives |
NL6608066A (de) * | 1965-06-17 | 1966-12-19 | ||
US3551450A (en) * | 1967-04-21 | 1970-12-29 | Sandoz Ag | 3-(2-aminoalkyl)-2-hydroxy-3-phenyl-indolines |
US3547947A (en) * | 1967-04-21 | 1970-12-15 | Sandoz Ag | Nitrogen-containing tricyclic compounds |
US3547945A (en) * | 1967-04-21 | 1970-12-15 | Sandoz Ag | 3-phenyloxindole derivatives |
US3897451A (en) * | 1973-04-27 | 1975-07-29 | Univ Ohio State Res Found | Synthesis of oxindoles from anilines and intermediates therein |
CA1137489A (en) * | 1977-09-20 | 1982-12-14 | Alessandro Bartolini | Derivatives of 1,2,3,3a,8,8a-hexadydropyrrolo (2,3-b) indole |
IT1109003B (it) * | 1977-09-20 | 1985-12-16 | Univ Firenze | Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo |
US4278667A (en) * | 1980-06-02 | 1981-07-14 | Chromalloy American Corporation | Method of treating tardive dyskinesia by oral dosage form of a physostigmine compound |
US5306825A (en) * | 1984-03-01 | 1994-04-26 | Consiglio Nazionale Delle Ricerche | Physostigmine derivatives with acetylcholinesterase inhibition properties, and the relative production process |
IT1199076B (it) * | 1984-03-01 | 1988-12-30 | Consiglio Nazionale Ricerche | Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione |
US4680172A (en) * | 1985-03-05 | 1987-07-14 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4765985A (en) * | 1985-03-05 | 1988-08-23 | Ciba-Geigy Corporation | Devices and methods for treating memory impairment |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
IT1225462B (it) * | 1987-04-03 | 1990-11-14 | Mediolanum Farmaceutici Srl | Sali organici di derivati della fisostigmina |
US5187165A (en) * | 1987-05-15 | 1993-02-16 | Hoechst-Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles |
JPH0781624B2 (ja) * | 1987-10-23 | 1995-09-06 | 株式会社クボタ | 作業車の走行用伝動構造 |
DK168069B1 (da) * | 1987-11-11 | 1994-01-31 | Hoffmann La Roche | Isoquinolinderivater og en fremgangsmaade til fremstilling af octahydroisoquinoliner ud fra derivaterne |
US4900748A (en) * | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
US4971992A (en) * | 1989-03-27 | 1990-11-20 | Hoechst-Roussel Pharmaceuticals Inc. | Carbonate derivatives of eseroline |
US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
US4937341A (en) * | 1989-09-28 | 1990-06-26 | Hoechst-Roussel Pharmaceuticals Inc. | Process for preparing N-aminocarbarbamates related to physostigmine |
US5260452A (en) * | 1989-11-03 | 1993-11-09 | Hoechst-Roussel Pharmaceuticals Inc. | 4- and 6-carbamates related to physostigmine and intermediates for the preparation thereof |
US5177101A (en) * | 1989-11-30 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
US4983616A (en) * | 1990-02-01 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds |
US5091541A (en) * | 1990-02-01 | 1992-02-25 | Hoechst-Roussel Pharmaceuticals Inc. | Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds |
US5216017A (en) * | 1990-05-11 | 1993-06-01 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrrolo[2,3-b]indole-ketones and analogs |
US5264587A (en) * | 1990-05-17 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Method of preparing α-oxopyrrolo[2,3-b]indole acetic acids and derivatives |
US5173497A (en) * | 1990-05-17 | 1992-12-22 | Hoechst-Roussel Pharmaceuticals Incorporated | Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs |
ES2113859T3 (es) * | 1990-06-27 | 1998-05-16 | Hoechst Marion Roussel Inc | Tetrahidroisoquinolinilcarbamatos de 1,2,3,3a,8,8a-hexahidro-1,3a,8-trimetilpirrolo(2,3-b)indol. |
EP0513703A3 (en) * | 1991-05-13 | 1993-01-13 | Magis Farmaceutici S.P.A. | Carbamate esters of eseroline having anticholinesterase activity, a process for their preparation and relative pharmaceutical compositions containing them as the active principle |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
US5206260A (en) * | 1991-11-07 | 1993-04-27 | Merck & Co., Inc. | Hexahydropyrrolo[2,3-b]indole derivatives |
US5302721A (en) * | 1992-07-21 | 1994-04-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Method of preparation of physostigmine carbamate derivatives from eseretholes |
-
1987
- 1987-05-15 US US07/049,894 patent/US4791107A/en not_active Expired - Lifetime
- 1987-07-14 NZ NZ221060A patent/NZ221060A/en unknown
- 1987-07-14 IL IL83190A patent/IL83190A0/xx unknown
- 1987-07-14 HU HU873208A patent/HU206717B/hu not_active IP Right Cessation
- 1987-07-15 EP EP87110184A patent/EP0253372B1/de not_active Expired - Lifetime
- 1987-07-15 PT PT85334A patent/PT85334B/pt not_active IP Right Cessation
- 1987-07-15 CA CA000542153A patent/CA1307788C/en not_active Expired - Fee Related
- 1987-07-15 ES ES87110184T patent/ES2060585T3/es not_active Expired - Lifetime
- 1987-07-15 AT AT87110184T patent/ATE112278T1/de not_active IP Right Cessation
- 1987-07-15 KR KR1019870007631A patent/KR960003614B1/ko not_active IP Right Cessation
- 1987-07-15 JP JP62175005A patent/JP2716099B2/ja not_active Expired - Fee Related
- 1987-07-15 IE IE191187A patent/IE64429B1/en not_active IP Right Cessation
- 1987-07-15 AU AU75668/87A patent/AU612583B2/en not_active Ceased
- 1987-07-15 DK DK367987A patent/DK367987A/da not_active Application Discontinuation
- 1987-07-15 DE DE3750596T patent/DE3750596T2/de not_active Expired - Fee Related
-
1992
- 1992-10-16 US US07/962,080 patent/US5663190A/en not_active Expired - Fee Related
- 1992-10-16 US US07/962,079 patent/US5547977A/en not_active Expired - Fee Related
- 1992-10-28 US US07/967,534 patent/US5541216A/en not_active Expired - Fee Related
-
1995
- 1995-06-06 US US08/466,013 patent/US5639892A/en not_active Expired - Fee Related
- 1995-06-07 US US08/486,256 patent/US5541340A/en not_active Expired - Fee Related
- 1995-06-07 US US08/479,197 patent/US5621114A/en not_active Expired - Fee Related
- 1995-06-07 US US08/483,696 patent/US5550253A/en not_active Expired - Fee Related
- 1995-06-07 US US08/483,700 patent/US5550254A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2716099B2 (ja) | 1998-02-18 |
AU612583B2 (en) | 1991-07-18 |
US5550253A (en) | 1996-08-27 |
EP0253372A2 (de) | 1988-01-20 |
US5639892A (en) | 1997-06-17 |
DE3750596T2 (de) | 1995-03-23 |
US5547977A (en) | 1996-08-20 |
US5541340A (en) | 1996-07-30 |
JPS6323881A (ja) | 1988-02-01 |
DK367987D0 (da) | 1987-07-15 |
PT85334B (pt) | 1990-04-30 |
HUT47275A (en) | 1989-02-28 |
HU206717B (en) | 1992-12-28 |
EP0253372A3 (en) | 1989-11-08 |
CA1307788C (en) | 1992-09-22 |
US5621114A (en) | 1997-04-15 |
US4791107A (en) | 1988-12-13 |
US5550254A (en) | 1996-08-27 |
AU7566887A (en) | 1988-01-21 |
DE3750596D1 (de) | 1994-11-03 |
IE871911L (en) | 1988-01-16 |
EP0253372B1 (de) | 1994-09-28 |
US5663190A (en) | 1997-09-02 |
ES2060585T3 (es) | 1994-12-01 |
PT85334A (en) | 1987-08-01 |
KR880001656A (ko) | 1988-04-25 |
DK367987A (da) | 1988-01-17 |
US5541216A (en) | 1996-07-30 |
IE64429B1 (en) | 1995-08-09 |
KR960003614B1 (ko) | 1996-03-20 |
NZ221060A (en) | 1990-11-27 |
IL83190A0 (en) | 1987-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE112278T1 (de) | 1,2,3,3a,8,8a-hexahydro-1,3a,8- trimethylpyrrolo(2,3-b>indole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE163012T1 (de) | N-substituierte 4-pyrimidinamine und - pyrimidindiamine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel | |
HUT52058A (en) | Process for producing n-substituted nicotinamide derivatives | |
DE3772905D1 (de) | Alpha-alkyl-4-amino-3-chinolin-methanole und 1-(4-aralkylamino-3-chinolyl)alkanone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE69022294D1 (de) | N-Heteroaryl-purin-6-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
DE69028605D1 (de) | Aminocarbonylcarbamate verwandt mit Physostigmin, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
DE69020205D1 (de) | Carbonate des Eserolins, ein Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel. | |
ATE56713T1 (de) | 1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE68918402D1 (de) | 1,2,3,4-Tetrahydro-1,9-Acridindiamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. | |
AU4583489A (en) | New indole derivatives, process for preparing them and pharmaceutical compositions containing them | |
DE69131546D1 (de) | Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepine und verwandte Analoge, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE52510T1 (de) | Benzo(c>-1,5-naphthyridine, ein verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. | |
IE811329L (en) | Derivatives of mercaptoacylprolines and pipecolic acids. | |
ATE47593T1 (de) | Spiro(benzofuran-2(3h), 1'-cycloheptane>, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE3576822D1 (de) | Pyrrolo(1,2-b)(1,2,5)triazepine, verfahren und zwischenprodukte zu ihrer herstellung und ihre anwendung als arzneimittel. | |
DE3883434D1 (de) | Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen. | |
ATE66219T1 (de) | Pyrrol-derivate, ihre herstellung und pharmazeutische zusammenstellungen, die sie enthalten. | |
ATE67206T1 (de) | 6h-isoxazolo(3,4-d>pyrazolo(3,4-b>pyridine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |